戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 isoform protein of the Na(+)/H(+) exchanger (NHE1).
2 ed expression of the Na(+)/H(+) exchanger-1 (NHE1).
3 re mediated by the sodium-hydrogen exchanger NHE1.
4 transporter (NCX1.1) much more potently than NHE1.
5 pression and transport of the Na-H exchanger NHE1.
6 in (CaM) binding to the regulatory domain of NHE1.
7 ignaling pathways, which converge to inhibit NHE1.
8 ts lacking H(+) efflux by the Na-H exchanger NHE1.
9 xyl-terminal 190 amino acids (625 to 815) of NHE1.
10 s imparting partial inhibitor sensitivity to NHE1.
11  back to cytosolic H+, which is extruded via NHE1.
12 th amiloride or a Na(+)-free bath to inhibit NHE1.
13 f cell-cell-adhesion by extracellular pH and NHE1.
14 hat are strengthened by protons extruded via NHE1.
15  is reversible by blockade of sodium channel NHE1.
16 d extrusion on NBC by 40%, without affecting NHE1.
17 f CHP3 are important elements for regulating NHE1.
18 t that CD44 interaction with a ROK-activated NHE1 (a Na(+)-H(+) exchanger) in cholesterol/ganglioside
19  we identify how the Na(+)/H(+)-exchanger 1 (NHE1), a key regulator of cellular pH homeostasis, is re
20 teract with the sodium hydrogen exchanger 1 (NHE1), a major regulator of intracellular pH.
21 ed activity of the sodium/hydrogen exchanger NHE1, a known regulator of skin pH.
22   We conclude that these opposite effects of NHE1 act synergistically during the metastatic cascade.
23 hibiting RSK in cardiomyocytes would prevent NHE1 activation and decrease I/R-mediated injury.
24                                     However, NHE1 activation by 100 micromol/L H2O2 was significantly
25 es support a role of IgE-mediated macrophage Nhe1 activation in atherosclerosis.
26 tor-alpha (TGFalpha) requires PI3K-dependent NHE1-activation and subsequent pHi alkalization.
27 ipase A(2) and sodium/hydrogen antiporter 1 (NHE1) activities.
28  and activity, and (ii) inhibition of ROK or NHE1 activity (by treating cells with a ROK inhibitor, Y
29                                   Inhibiting NHE1 activity after TGFalpha stimulation with 10 muM of
30      Inhibition of LC-CoA catabolism reduced NHE1 activity and enhanced apoptosis, whereas inhibition
31  proximal tubule LC-CoA generation preserved NHE1 activity and protected against apoptosis.
32 cancer cells occurs as a result of increased NHE1 activity and, while much is known about the pathoph
33 summary, RSK is a novel regulator of cardiac NHE1 activity by phosphorylating NHE1 serine 703 and a n
34                     These results imply that NHE1 activity disrupts Na+ and Ca2+ homeostasis and cont
35  increased NHE1 phosphorylation, and reduced NHE1 activity following intracellular acidosis.
36 gical inhibition of endogenous PKB increased NHE1 activity following intracellular acidosis.
37 enosine A(1) receptor-mediated regulation of NHE1 activity in ARVM, the mechanism of which appears to
38                                              NHE1 activity in atRBCs is exceptionally robust in that
39                                              NHE1 activity is increased by phosphorylation of NHE1 re
40                                              NHE1 activity is stable with perfusion of nonhydrolyzabl
41 wnstream Akt survival signaling, and dampens NHE1 activity through competitive inhibition and depleti
42 (+) exchange, and blunted apoptosis, whereas NHE1 activity was decreased in cells enriched with PI(3,
43                                              NHE1 activity was significantly increased during 10-60 m
44                    As a result of persistent NHE1 activity, cytosolic free levels of sodium ([Na(+)](
45  with NHE1, necessary for agonist-stimulated NHE1 activity, were increased by I/R and inhibited by 70
46 ing fibronectin expression is independent of NHE1 activity.
47 s-expressing DN-RSK (Ad.DN-RSK) and measured NHE1 activity.
48  703 of NHE1, stimulating 14-3-3 binding and NHE1 activity.
49 e c release were attenuated by inhibition of NHE1 activity.
50  increases sarcolemmal Na(+)/H(+) exchanger (NHE1) activity in cardiac myocytes by an ERK/RSK-depende
51 macrophages by enhancing Na+/H+ exchanger 1 (NHE1) activity.
52          We hypothesized that stimulation of NHE1 after cerebral ischemia contributes to the disrupti
53             Furthermore, genetic ablation of Nhe1 also resulted in Purkinje cell axon degeneration, p
54 did not prevent the interaction of CHP3 with NHE1, although the D123A mutant no longer showed elevate
55                                              NHE1 and -4 are expressed at the NPE basolateral margin.
56          Immunolocalization studies revealed NHE1 and -4 in native and cultured NPE.
57 ane, which is required for the activation of NHE1 and an increase in submembranous intracellular pH o
58 During myocardial ischemia, low pH activates NHE1 and causes increased intracellular calcium levels a
59  cell rows, resulting in additive effects of NHE1 and epidermal growth factor.
60 1-deficient mice, immunocomplex formation of Nhe1 and FcepsilonR1 in IgE-activated macrophages, and N
61 (standard form) and two signaling molecules (NHE1 and Hyal-2) are closely associated in a complex in
62 s following in vitro ischemia phosphorylates NHE1 and increases its activity, which subsequently cont
63 , these findings reveal a novel function for NHE1 and NCX1 in membrane blebbing and permeability, and
64 1.1 at </=1muM, while dually inhibiting both NHE1 and NCX1.1 at >/=20muM.
65 and SEA0400 are more selective inhibitors of NHE1 and NCX1.1 than amiloride or DCB, respectively.
66                                              NHE1 and NHE2 are not regulated by trafficking.
67 action of two Na(+)/H(+) exchanger isoforms: NHE1 and NHE3.
68  mellitus by interfering with the actions of NHE1 and NHE3.
69 s may act through increased activity of both NHE1 and NHE3.
70 ned, at least in part, by dual inhibition of NHE1 and of Na(+)-dependent calcium efflux by isoform 1.
71 l type-specific differences in regulation of NHE1 and other target genes.
72 with U0126 abolished phosphorylation of both NHE1 and p90(RSK).
73 s and that ROCK1-mediated phosphorylation of NHE1 and pH change is an essential event required for th
74 ultiple drug targets including inhibition of NHE1 and sodium-calcium exchange.
75  was examined in the parotid acinar cells of Nhe1(-/-) and Nhe2(-/-) mice, both of which exhibited im
76 E activates macrophage Na(+)-H(+) exchanger (Nhe1) and induces extracellular acidification and cell a
77 brane acid extrusion by Na(+)/H(+) exchange (NHE1) and Na(+)-HCO3(-) co-transport (NBC) is essential
78                   Sodium-proton exchanger 1 (NHE1) and sodium-calcium exchanger 1 (NCX1) are membrane
79 sphorylation of sodium-hydrogen exchanger 1 (NHE1), and inhibition of NHE1 with 5'-N-ethyl-N-isopropy
80  Finally, we confirmed that the keratinocyte NHE1 antiporter is regulated by extracellular pH indepen
81  was enhanced by acidic pH, and abolished by NHE1 Arg/Lys to Ala mutations within two juxtamembrane d
82 ce of melanoma cell-cell adhesion on pHe and NHE1 as a modulator.
83 f Na(+)/H(+) exchange activity and implicate NHE1 as a possible downstream effector contributing to m
84              We uncovered the Na-H exchanger NHE1 as a potential MAPK scaffold, found links between H
85 esults further implicate helix M9 and EL5 of NHE1 as important elements involved in cation transport
86 nsistent with this, membrane localization of NHE1 at axon terminals was greatly reduced in Chp1-defic
87 olog (atNHE1) that is 79% identical to human NHE1 at the amino acid level.
88  present in the sarcolemma, colocalized with NHE1 at the intercalated disc regions, increased NHE1 ph
89  resident plasma membrane isoforms including NHE1 (basolateral) and NHE2 (apical), recycling isoforms
90                Our data fulfill criteria for NHE1 being a bona fide Akt substrate, including direct p
91  with the structurally similar PI(4,5)P2 for NHE1 binding.
92 oforms of CHP1 were defective in stimulating NHE1 biosynthetic maturation.
93                              Inactivation of NHE1 blocked IgE-induced macrophage production of inflam
94 ating cells with a ROK inhibitor, Y27632, or NHE1 blocker, S-(N-ethyl-N-isopropyl) amiloride, respect
95   OGD/REOX not only increased the V(max) for NHE1 but also shifted the K(m) toward decreased [H(+)](i
96 changes of hydrophobic mismatch can modulate NHE1 but do not underlie its volume sensitivity.
97                                              NHE1 (but not NHE3) is reversibly activated by cell shri
98                                      Ectopic NHE1, but not NHE3, expression rescued NHE1-null cells f
99 reased NGF-induced inhibition of basolateral NHE1 by 45%.
100 he plasma membrane sodium-hydrogen exchanger NHE1 by Akt increases exchanger activity (H(+) efflux).
101            Rapamycin-sensitive inhibition of NHE1 by NGF was associated with an increased level of ph
102 )-antiporter resembling the human antiporter NHE1, by electron crystallography of 2D crystals in a ra
103 ay and surface plasmon resonance assays, the NHE1 C terminus bound phospholipids with low affinity an
104 ein comprising amino acids 516 to 815 of the NHE1 carboxyl-terminal regulatory domain.
105 n was similarly defective in both htt(-) and nhe1(-) cells in a K(+)-based buffer, and the normal loc
106 witch mechanism to selectively stabilize the NHE1.CHP3 complex at the cell surface in a conformation
107 ulate fraction, which contained the cellular NHE1 complement; this effect was abolished by pretreatme
108                                        Thus, NHE1 contributes to collective migration and epithelial
109 d competing LC-CoAs disrupted binding of the NHE1 cytosolic tail to PI(4,5)P2.
110 e normally quiescent Na(+)/H(+) exchanger-1 (NHE1) defends against PTC apoptosis, and is regulated by
111                           In Apoe(-/-) mice, Nhe1-deficiency or anti-IgE antibody reduces atheroscler
112 in intracellular pH, nor is it attenuated in NHE1-deficient cells, indicating fibronectin expression
113 xchanger activity increased nearly 4-fold in Nhe1-deficient mice, despite only minimal or any change
114  signaling in IgE-activated macrophages from Nhe1-deficient mice, immunocomplex formation of Nhe1 and
115 ent PI(4,5)P(2) and PI(3,4,5)P(3) effects on NHE1-dependent Na(+)/H(+) exchange and apoptosis were co
116  hypothesize that apoptotic stress activates NHE1-dependent Na(+)/H(+) exchange, and NHE1-ERM interac
117 rotein-mediated translocation of PP2A(c) and NHE1 dephosphorylation.
118  with amiloride and NGF but does not act via NHE1, did not affect cellular F-actin content.
119 ibiting isoform 1 of sodium-proton exchange (NHE1), direct acidification was shown to be cytostatic r
120          LC-CoAs and the cytosolic domain of NHE1 directly interacted, with an affinity comparable to
121                                Inhibition of NHE1 disrupts membrane blebbing and decreases changes in
122 ates NHE1-dependent Na(+)/H(+) exchange, and NHE1-ERM interaction is required for cell survival signa
123 have also been found to be key activators of NHE1 exchanger activity; however, the crosstalk between
124 hat affect phosphorylation; however, whether NHE1 exists in large multi-protein complexes is unknown.
125 , in breast cancer cells, PPARgamma inhibits NHE1 expression and the inflammatory response, and it fu
126 ryptic lamellipodia in submarginal cell rows NHE1 expression disrupted the morphology of epithelial c
127           In the present study, we show that NHE1 expression in MDCK-II kidney epithelial cells accel
128                                              NHE1 expression increased the number of migration finger
129                                     Finally, NHE1 expression resulted in disorganized development of
130              We found that in vivo epidermal NHE1 expression was upregulated within hours of barrier
131            SC barrier break also upregulates NHE1 expression, but this response seems to be mediated
132 e the effects of barrier break in regulating NHE1 expression, suggesting that SC alkalinization is th
133 nization is the major stimulus for increased NHE1 expression.
134           Exogenous Na(+) /H(+) exchanger 1 (NHE1) expression stimulated the collective migration of
135 n, is linked to decreased Na+/H+ antiporter (NHE1) expression.
136 cepsilonR1 in IgE-activated macrophages, and Nhe1-FcepsilonR1 colocalization in atherosclerotic lesio
137 K1/2) play a role in stimulation of neuronal NHE1 following in vitro ischemia.
138 ic ablation or pharmacological inhibition of NHE1 following OGD/REOX.
139 egulation of Na(+)/H(+) exchanger isoform 1 (NHE1) following cerebral ischemia are not well understoo
140                         We previously cloned NHE1 from Amphiuma tridactylum (AtNHE1) and Pleuronectes
141         Furthermore, these data suggest that NHE1 functions as a metabolic sensor for lipotoxicity.
142 d in vitro a glutathione S-transferase (GST)-NHE1 fusion protein comprising amino acids 516 to 815 of
143 say, purified PP2A(c) dephosphorylated a GST-NHE1 fusion protein containing aa 625-747 of the NHE1 re
144     PKBalpha-mediated phosphorylation of GST-NHE1 fusion proteins containing overlapping segments of
145 rylation analysis of mutated (Ser-->Ala) GST-NHE1 fusion proteins revealed that PKBalpha-mediated pho
146 in, tropomyosin, ICAM-4, GLUT4, Na/K-ATPase, NHE1, GPA, CD47, Duffy, and Kell were reduced.
147 al signaling cascade involving TGFalpha>PI3K>NHE1&gt;pHi alkalization, which leads to a permissible envi
148 s and a similar relationship between Htt and Nhe1 have not been reported for mammalian neurons and de
149       NHE1(+/+) mice treated with HOE 642 or NHE1 heterozygous mice exhibited a approximately 33% dec
150 us to the amiloride- and HOE-sensitive human NHE1 (hNHE1), AtNHE1 is insensitive to HOE-type and PaNH
151 +)/H(+) exchange in atRBCs is mediated by an NHE1 homolog (atNHE1) that is 79% identical to human NHE
152 nging the extracellular loops (ECL) of human NHE1 (huNHE1) and chNHE1 and by ECL replacement with a h
153 alated discs are commonly located, and where NHE1 immunostaining is prominent.
154 ced apoptosis, indicating the involvement of NHE1 in apoptosis.
155 y may play in the disrupted functionality of NHE1 in breast cancer metastasis.
156 ally, our results obtained by expressing rat NHE1 in Caenorhabditis elegans suggest that a conserved
157                                  The role of NHE1 in cardiac injury has prompted interest in the deve
158                                              NHE1 in Chinese hamster ovary fibroblasts (but not NHE3
159  (JH+) are equivalent to currents >20 pA for NHE1 in Chinese hamster ovary fibroblasts, >200 pA for N
160 inese hamster ovary fibroblasts, >200 pA for NHE1 in guinea pig ventricular myocytes, and 5-10 pA for
161  mutant no longer showed elevated binding to NHE1 in the presence of Ca(2+) when assessed using in vi
162  is known about the pathophysiologic role of NHE1 in tumor progression with regard to ion flux, the r
163 d significant co-localization of PP2A(c) and NHE1, in intercalated disc regions.
164 I(4,5)P2], but pathophysiologic triggers for NHE1 inactivation are unknown.
165 edict that other functions shared by Akt and NHE1, including cell growth and survival, might be regul
166 migration of the front row of cells, whereas NHE1 increased that of submarginal cell rows, and the tw
167 ll blebbing; cells become swollen because of NHE1 induced intracellular sodium accumulation.
168                         Our study found that NHE1 induced sodium influx is a driving force for membra
169 vation of RSK1, which via phosphorylation of NHE1 induces cardiomyocyte apoptosis.
170 rug-drug interaction potential starting from NHE1 inhibitor sabiporide.
171 covery was eliminated in the presence of the NHE1 inhibitor zoniporide.
172 ults were recapitulated by treatment with an NHE1 inhibitor, 5-(N,N-hexamethylene) amiloride (HMA).
173 re also inhibited by the Na+-H+ exchanger-1 (NHE1) inhibitor dimethylamiloride, but not by the NHE3 i
174  has prompted interest in the development of NHE1 inhibitors for the treatment of heart failure.
175 affinity comparable to that of the PI(4,5)P2-NHE1 interaction, and competing LC-CoAs disrupted bindin
176  addition to mediating Na(+)/H(+) transport, NHE1 interacts with ezrin/radixin/moesin (ERM), which te
177                                              NHE1 interacts with multiple regulatory proteins that af
178                        Our data suggest that NHE1 is a novel PKB substrate and that its PKB-mediated
179 cs and transverse tubules (t-tubules), while NHE1 is absent from t-tubules.
180  In human melanoma, the Na(+)/H(+) exchanger NHE1 is an important modifier of the tumour nanoenvironm
181                                              NHE1 is constitutively active in a neoplastic microenvir
182            Expressed in AP-1 cells, however, NHE1 is insensitive to these agents but remains sensitiv
183  expressing NHE1-KRA2 because scaffolding by NHE1 is mislocalized.
184 t NHE1 that lacks H(+) efflux, and wild-type NHE1 is not activated in fibroblasts expressing mutation
185                               H(+) efflux by NHE1 is not necessary for release of Cdc42-guanosine dip
186     Our objectives were to determine whether NHE1 is phosphorylated by protein kinase B (PKB), identi
187     These data suggest that the keratinocyte NHE1 is regulated by extracellular pH.
188             In response to apoptotic stress, NHE1 is stimulated by PI(4,5)P(2), which leads to PI 3-k
189                       The membrane domain of NHE1 is sufficient for ion exchange.
190           The Na(+)/H(+)Exchanger isoform 1 (NHE1) is a highly versatile, broadly distributed and pre
191                  Na+/H+ exchanger isoform 1 (NHE1) is a major acid extrusion mechanism after intracel
192         Sodium-hydrogen exchanger isoform 1 (NHE1) is a ubiquitously expressed transmembrane ion chan
193 previously shown that the Na+/H+ antiporter (NHE1) is an essential endogenous pathway responsible for
194 n that regulates the Na(+)/H(+) exchanger 1 (NHE1), is highly expressed in various mouse tissues such
195    We conclude that functional NHE2, but not NHE1, is essential for mouse gastric epithelial restitut
196 ulates the plasmalemmal Na(+)/H(+) exchanger NHE1 isoform by enhancing its rate of oligosaccharide ma
197  Molecular manipulations of the prototypical NHE1 isoform have implicated several predicted membrane-
198 ogen exchanger in the heart and vasculature (NHE1 isoform) and the kidneys (NHE3 isoform) may serve a
199           However, aside from the ubiquitous NHE1 isoform, their relative contributions are poorly un
200 tion of phosphorylation of p90(RSK), a known NHE1 kinase.
201                             These changes in NHE1 kinetics were absent when MAPK/ERK kinase (MEK) was
202 duction is nearly absent in cells expressing NHE1-KRA2 because scaffolding by NHE1 is mislocalized.
203 d TGF-beta activation, and they suggest that NHE1-KRA2 can be used for obtaining a mechanistic unders
204        Our data indicate that scaffolding by NHE1-KRA2 dominantly suppresses fibronectin synthesis an
205 ane protrusions or lamellipodia but a mutant NHE1-KRA2 lacking binding sites for PI(4,5)P2 and the ER
206                                    Decreased NHE1 levels lead to increased SC pH, which results in de
207 d the two stimuli were additive Accordingly, NHE1 localized not only to the leading edges of leader c
208                                              NHE1 localized to the leading edges of leader cells, as
209                    In fibroblasts, wild-type NHE1 localizes to the distal margin of membrane protrusi
210 and activate an Na(+)/H(+) exchanger type-1 (NHE1), may underlie tyrosine kinase inhibitor resistance
211 plasma membrane lipids, we hypothesized that NHE1-mediated cell survival is dynamically regulated by
212  Our data identify T779 as a site regulating NHE1-mediated cellular acid extrusion and provides a mol
213 ronal axons and that selective disruption of NHE1-mediated proton homeostasis in axons can lead to de
214                                              NHE1(+/+) mice treated with HOE 642 or NHE1 heterozygous
215 usion induced 84.8 +/- 8.0 mm3 infarction in NHE1(+/+) mice.
216                Indeed, the parotid glands of Nhe1(-/-) mice expressed higher levels of carbonic anhyd
217 ory changes in the exocrine parotid gland of Nhe1(-/-) mice that together attenuate the severity of i
218 94) slows restitution 72-83% in wild-type or NHE1(-/-) mice.
219 complexes in the parotid plasma membranes of Nhe1(-/-) mice.
220 ding limb (MTAL), inhibiting the basolateral NHE1 Na(+)/H(+) exchanger with amiloride or nerve growth
221 k ascending limb, inhibiting the basolateral NHE1 Na(+)/H(+) exchanger with nerve growth factor (NGF)
222 ial for the ROCK1-induced phosphorylation of NHE1 (Na(+)/H(+)exchanger 1), which is involved in the r
223 vation of RSK and interaction of 14-3-3 with NHE1, necessary for agonist-stimulated NHE1 activity, we
224                                           In NHE1(+/+) neurons, OGD caused a twofold increase in [Na+
225 EOX evoked a 1.5-fold increase in [Ca2+]i in NHE1(+/+) neurons, which was abolished by inhibition of
226 ed intake (P = 0.003) as were all NHE genes (NHE1, NHE2, and NHE3; P < 0.05).
227 ding AE3, AQP4, AQP5, CFTR, ClC2gamma, KCC1, NHE1, NKAalpha1, NKAbeta1, NKAbeta2, NKAbeta3, and NKCC1
228 topic NHE1, but not NHE3, expression rescued NHE1-null cells from apoptosis induced by staurosporine
229 ase in Cl(-)/HCO(3)(-) exchanger activity in Nhe1-null mice suggesting that increased anion exchange
230 -kinase, and Akt inhibition in wild-type and NHE1-null PTCs.
231 ed that PKBalpha-mediated phosphorylation of NHE1 occurred principally at Ser648.
232 s 364-415) of a cysteine-less variant of rat NHE1 on its kinetic and pharmacological properties.
233                          Genetic ablation of NHE1 or HOE 642 treatment had no effects on the OGD-medi
234  which was abolished by inhibition of either NHE1 or reverse-mode operation of Na+/Ca2+ exchange.
235 in Apoe(-/-) mice receiving bone marrow from Nhe1- or IgE receptor FcepsilonR1-deficient mice, blunte
236 ed in mammalian cells lacking H(+) efflux by NHE1, our current data suggest that full-length Aip1 fac
237                            Acidification and NHE1 overexpression both reduce cell-cell adhesion stren
238 are strongly impaired under acidification or NHE1 overexpression.
239     In addition to Na-H exchanger isoform-1 (NHE1), pHi acidification is regulated by a HCO3-dependen
240 mation about the pathogenetic role of a TESC-NHE1-pHi axis in mediating sorafenib resistance in AML.
241                                              NHE1-phosphoinositide binding was enhanced by acidic pH,
242 y, the authors reported ERK1/2, p90(RSK) and NHE1 phosphorylation after 2 hours.
243 enuate the phenylephrine-induced increase in NHE1 phosphorylation and activity was lost in the presen
244  HA/CD44-activated Rho kinase (ROK) mediates NHE1 phosphorylation and activity, and (ii) inhibition o
245                                              NHE1 phosphorylation contributes to Na(+)/H(+) exchange
246                      We examined the role of NHE1 phosphorylation during activation by OCS, using an
247  is the first reported evidence of increased NHE1 phosphorylation during OCS in any vertebrate cell t
248 tyladenosine (CPA) inhibited the increase in NHE1 phosphorylation induced by the alpha(1)-adrenorecep
249  at the intercalated disc regions, increased NHE1 phosphorylation, and reduced NHE1 activity followin
250 N-isopropyl) amiloride, respectively) blocks NHE1 phosphorylation/Na(+)-H(+) exchange activity, reduc
251 ntributes to tubular atrophy by severing the NHE1-PI(4,5)P2 interaction, thereby lowering the apoptot
252 icate that the (Na+)-H+ exchanger isoform 1 (NHE1) plays a critical role in myocardial ischemia and r
253  myocytes, suggesting that, by guarding pHi, NHE1 preferentially protects gap junctional communicatio
254 uggesting a mechanism for how H(+) efflux by NHE1 promotes Cdc42 activity to generate a positive feed
255                             We conclude that NHE1 promotes cell survival by dual mechanisms: by defen
256  apical membranes of surface epithelium, and NHE1 protein amount or localization is unchanged.
257  cariporide (HOE 642) or genetic ablation of NHE1 reduced OGD-induced cell death by approximately 40-
258 to PaNHE1, and we thereby identified several NHE1 regions involved in inhibitor interaction.
259 to apical and lateral PTC domains, increased NHE1-regulated Na(+)/H(+) exchange, and blunted apoptosi
260                    Apoptotic stimuli induced NHE1-regulated Na(+)/H(+) transport, as demonstrated by
261      These results indicate that basolateral NHE1 regulates apical NHE3 and HCO3- absorption in the M
262                                     Although NHE1 regulates intracellular pH homeostasis, fibronectin
263                         The Na+/H+ exchanger NHE1 regulates proximal tubule cell survival through int
264  fusion protein containing aa 625-747 of the NHE1 regulatory domain, which had been pre-phosphorylate
265 kely via RSK-mediated phosphorylation of the NHE1 regulatory domain.
266  activity is increased by phosphorylation of NHE1 residue T779, which is specifically dephosphorylate
267 th factor in fibroblasts expressing a mutant NHE1-S648A.
268 dium are inhibited in fibroblasts expressing NHE1-S648A.
269  of cardiac NHE1 activity by phosphorylating NHE1 serine 703 and a new pathological mediator of I/R i
270 elicited responses in cells transfected with NHE1 siRNA but not in those transfected with ENaCalpha o
271                 The Na(+) /H(+) exchanger 1 (NHE1, SLC9A1) is an important regulator of motility in m
272 fter TGFalpha stimulation with 10 muM of the NHE1-specific inhibitor N-Methyl-N-isobutyl Amiloride (M
273 S6 kinase (RSK) phosphorylated serine 703 of NHE1, stimulating 14-3-3 binding and NHE1 activity.
274  uniform pHi recovery from acidosis, whereas NHE1 stimulation induces pHi non-uniformity during recov
275 on and provides a molecular understanding of NHE1 substrate selection by CN, specifically, and how ph
276 olding by the plasma membrane Na-H exchanger NHE1 suppresses fibronectin expression, secretion, and a
277 at CHP1 assists in the full glycosylation of NHE1 that is necessary for the membrane localization of
278 activated in fibroblasts expressing a mutant NHE1 that lacks H(+) efflux, and wild-type NHE1 is not a
279 -life and near maximal transport velocity of NHE1 to a similar extent.
280 th ezrin/radixin/moesin (ERM), which tethers NHE1 to cortical actin cytoskeleton to regulate cell sha
281  phosphorylation mediates the recruitment of NHE1 to the invadopodium compartment, where it locally i
282 e biosynthetic processing and trafficking of NHE1 to the plasma membrane nor did it affect the H(+) s
283 sults reveal an on-off switch model, whereby NHE1 toggles between weak interactions with PI(4,5)P(2)
284 diffusion distances, particularly to surface NHE1 transporters mediating high membrane flux.
285          In the present study, expression of NHE1 was detected in cultured mouse cortical neurons.
286 based buffer, and the normal localization of Nhe1 was disrupted in the htt(-) mutant.
287               At 10 min REOX, phosphorylated NHE1 was increased with a concurrent elevation of phosph
288                        We next asked whether NHE1 was regulated by barrier status per se, or by the S
289                                              NHE1 was upregulated by alkalinizing SC pH, whereas this
290 ent of barrier status, by demonstrating that NHE1 was upregulated in cultured keratinocytes exposed t
291  barrier perturbations, we asked whether the NHE1 was, in turn, regulated by changes in barrier statu
292                  Na+/H+-exchanger isoform 1 (NHE1) was present on hair-cell soma membranes and was li
293 lcineurin Abeta and the Na(+)/H(+) exchanger NHE1 were observed in VSMCs.
294 ity, and H(+) efflux by Na-H(+) exchanger 1 (NHE1), which is necessary at the front of migrating cell
295 (NHE) activity is mediated by NHE isoform 1 (NHE1), which is subject to regulation by protein kinases
296 biquitous plasma membrane Na+/H+exchanger-1 (NHE1), which uses a highly conserved process to transfer
297 two endogenous mechanisms, namely, sPLA2 and NHE1, which are known to be important for acidification
298 mma activates expression of the pH regulator NHE1, which is associated with tumor progression.
299 drogen exchanger 1 (NHE1), and inhibition of NHE1 with 5'-N-ethyl-N-isopropyl-amiloride blocks H/R in
300                                Inhibition of NHE1 with the potent inhibitor cariporide (HOE 642) or g
301 tion of the ubiquitous Na(+)/H(+) exchanger, NHE1, with its commonly used inhibitors, amiloride- and

 
Page Top